The Dayton School Department says it will roll out a fully electric school bus fleet this month thanks to a $1.5 million federal grant. The York County school district announced Tuesday that it took ...

Eli Lilly should become a much bigger money machine with multiple growth drivers in its product lineup and a promising ...

This Short discusses the potential growth of a $100 investment over time, using three examples. Investing $100 in Eli Lilly ...

The Golden Globes have a reputation for being Hollywood’s least serious awards show, allowing us all to revel in the mess.

It’s ordinary people, and not superheroes, who bring about justice and change in the real world. In “Lilly,” writer-director ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against the other healthcare stocks Jim Cramer has made bold predictions about. Healthcare has been ...

Reports indicate he was actually taking Eli Lilly's (NYSE: LLY) weight-loss drug Mounjaro. Eli Lilly's stock has been a strong winner over the past few years, powered by its portfolio of glucagon ...

Patients taking a compounded alternative to Eli Lilly's weight loss drug Zepbound will need to transition to the name-brand version in early 2025 Charlotte Phillipp is a Weekend Writer-Reporter at ...

Just to put into perspective how big a tailwind that weight loss space is for these companies, consider that Lilly's market value is larger than Pfizer's, Moderna's, and J&J's combined!

Enter Eli Lilly (NYSE: LLY) and Novo Nordisk (NYSE: NVO), the makers behind blockbuster glucagon-like peptide-1 (GLP-1) agonists such as Mounjaro, Zepbound, Ozempic, and Wegovy -- all of which are ...

The United States Food and Drug Administration says the shortage of Eli Lilly’s Zepbound and Mounjaro drugs has been resolved and that specialty pharmacies and online companies need to stop ...